B is the answer and the winners are Solace and Eze
Details Below:
Enalapril is an angiotensin-converting enzyme (ACE) inhibitor, which causes
a decreased arterial and venous vasoconstriction and a decreased blood
volume. ACE inhibitors are considered as first-line therapy in the management
of heart failure because it has been shown that they reduce symptoms and
improve prognosis. They are also used in hypertension as they reduce salt and
water retention. The addition of enalapril to AB’s therapy was an important
therapeutic intervention undertaken during hospitalisation. Before admission
the patient had a deterioration in the heart failure condition and required
further therapeutic intervention to correct progression of the disease. By
choosing to include enalapril in AB’s therapy, the first-line management of
congestive heart failure is now being followed.
B is the answer and the winners are Solace and Eze
Details Below:
Enalapril is an angiotensin-converting enzyme (ACE) inhibitor, which causes
a decreased arterial and venous vasoconstriction and a decreased blood
volume. ACE inhibitors are considered as first-line therapy in the management
of heart failure because it has been shown that they reduce symptoms and
improve prognosis. They are also used in hypertension as they reduce salt and
water retention. The addition of enalapril to AB’s therapy was an important
therapeutic intervention undertaken during hospitalisation. Before admission
the patient had a deterioration in the heart failure condition and required
further therapeutic intervention to correct progression of the disease. By
choosing to include enalapril in AB’s therapy, the first-line management of
congestive heart failure is now being followed.
B
B
A
B